Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Smart Sand, Inc. Common Stock (SND)

Mining & Quarrying Of Nonmetallic Minerals (no Fuels)

https://www.smartsand.com

Smart Sand Inc is a fully integrated frac sand supply and services company that offers complete mine-to-well site proppant supply and logistics solutions. It produces Northern White frac sand, which is a premium proppant used to enhance hydrocarbon recovery rates in the hydraulic fracturing of oil and natural gas wells. Its product portfolio includes Smart System, which includes SmartDepot Silo and SmartPath Loader. The company caters its products and services to oil and natural gas exploration and production companies and oilfield service companies. The majority of its revenue comes from Sand Sales, followed by logistics.

28420 HARDY TOLL ROAD, SUITE 130
SPRING, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/04/2016

Market Cap

88,420,005

Shares Outstanding

41,120,000

Weighted SO

41,117,111

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

NEX --.--%

LBRT --.--%

RES --.--%

MRC --.--%

RNGR --.--%

NR --.--%

PUMP --.--%

OIS --.--%

Beta

1.0810

Last Div

0.0000

Range

1.652-2.48

Chg

0.0198

Avg Vol

73437

Mkt Cap

88420005

Exch

NASDAQ

Country

US

Phone

281 231 2660

DCF Diff

-3.8455

DCF

5.8305

Div Yield

0.0000

P/S

0.2990

EV Multiple

3.9753

P/FV

0.3284

Div Yield %

0.0000

P/E

61.5936

PEG

3.4341

Payout

0.0432

Current Ratio

1.6581

Quick Ratio

1.0174

Cash Ratio

0.1601

DSO

37.7271

DIO

35.1252

Op Cycle

72.8523

DPO

13.3984

CCC

59.4539

Gross Margin

0.1204

Op Margin

0.0045

Pretax Margin

-0.0033

Net Margin

0.0044

Eff Tax Rate

2.3228

ROA

0.0038

ROE

0.0053

ROCE

0.0044

NI/EBT

-1.3228

EBT/EBIT

-0.7417

EBIT/Rev

0.0045

Debt Ratio

0.0534

D/E

0.0751

LT Debt/Cap

0.0089

Total Debt/Cap

0.0699

Int Coverage

1.8750

CF/Debt

1.1418

Equity Multi

1.4074

Rec Turnover

9.6747

Pay Turnover

27.2420

Inv Turnover

10.3914

FA Turnover

1.0913

Asset Turnover

0.8651

OCF/Share

0.5381

FCF/Share

0.1046

Cash/Share

0.1616

OCF/Sales

0.0705

FCF/OCF

0.1944

CF Coverage

1.1418

ST Coverage

1.2960

CapEx Coverage

1.2413

Div&CapEx Cov

1.2372

P/BV

0.3284

P/B

0.3284

P/S

0.2990

P/E

61.5936

P/FCF

21.8267

P/OCF

3.8280

P/CF

3.8280

PEG

3.4341

P/S

0.2990

EV Multiple

3.9753

P/FV

0.3284

DPS

0.0000

Latest Headlines (EST)

Benzinga Sep 22, 21:34 Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? GlobeNewswire Inc. Sep 22, 04:30 Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight GlobeNewswire Inc. Sep 20, 00:16 Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs The Motley Fool Jun 08, 14:08 SNDL Stock Is Up 35% This Year. Here's Why It'll Go Higher. The Motley Fool Jan 18, 05:21 3 Pot Stocks to Avoid Like the Plague in 2024 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Jan 07, 17:45 Ascendis Pharma Introduces Vision 2030 GlobeNewswire Inc. Dec 28, 16:15 Ascendis Pharma to Participate in the 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. Dec 28, 16:15 Ascendis Pharma to Participate in the 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. Dec 20, 08:30 Significant Health and Quality of Life Improvements Achieved in Children with Achondroplasia Treated for One Year with TransConâ„¢ CNP (Navepegritide) at 100 µg/kg/week GlobeNewswire Inc. Dec 19, 08:30 TransConâ„¢ hGH (lonapegsomatropin) Achieved Statistically Superior Outcomes Compared to Placebo in Phase 3 foresiGHt Trial of Adults with Growth Hormone Deficiency Benzinga Dec 18, 16:33 Switching From Tomatoes To Cost-Efficient Cannabis Boosts Company's Stock By 35%

Revenue Product Segmentation